As I said early huntleys have a $12 target on current prices. Surely with talk of $12, $24 and the like, at $4.50 there appears to be a much high risk to the upside than down.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
